Cargando…
A novel aptamer-based small RNA delivery platform and its application to cancer therapy
Major challenges such as nuclease degradation, rapid renal clearance, non-specific delivery, poor cellular uptake and inflammatory response have limited the clinical application of small RNA-mediated gene silencing. To overcome these challenges, we designed a novel targeting small RNA delivery platf...
Autores principales: | Tanno, Toshihiko, Zhang, Peng, Bailey, Christopher, Wang, Yin, Ittiprasert, Wannaporn, Devenport, Martin, Zheng, Pan, Liu, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chongqing Medical University
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308127/ https://www.ncbi.nlm.nih.gov/pubmed/37396505 http://dx.doi.org/10.1016/j.gendis.2022.05.004 |
Ejemplares similares
-
Anti-Mucin1 Aptamer-Conjugated Chitosan Nanoparticles for Targeted Co-Delivery of Docetaxel and IGF-1R siRNA to SKBR3 Metastatic Breast Cancer Cells
por: Jafari, Reza, et al.
Publicado: (2019) -
Development of a DNA Aptamer for Screening Neisseria meningitidis Serogroup B by Cell SELEX
por: Mirzakhani, Kimia, et al.
Publicado: (2018) -
Regulatory Effect of let-7f Transfection in Non-Small Cell Lung Cancer on its Candidate Target Genes
por: Zafari, Venus, et al.
Publicado: (2022) -
Hydrogel platform capable of molecularly resolved pulling on cells for mechanotransduction
por: Cheng, Nan, et al.
Publicado: (2022) -
BIRC5 Gene Disruption via CRISPR/Cas9n Platform Suppress Acute Myelocytic Leukemia Progression
por: Narimani, Manizheh, et al.
Publicado: (2019)